Press Release: Enfusion Announces Third Quarter 2024 Results

Dow Jones
2024-11-04

Enfusion Announces Third Quarter 2024 Results

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--November 04, 2024-- 

Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its third quarter 2024 financial results as part of its Q3 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com.

3Q24 Earnings Conference Call

Management will host a conference call today, November 4, 2024, at 8:30 AM ET to discuss the results.

To pre-register for the live teleconference of the second quarter earnings call, please use this link. To access this call, dial (888) 596-4144. The conference ID number is 9652536.

The earnings conference call will also be webcast live. Due to high call volumes, we urge interested parties to join the live webcast of the event through Enfusion's website at https://ir.enfusion.com/events-and-presentations/events/default.aspx.

About Enfusion

Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over 850 investment managers from 9 global offices spanning four continents.

Source: Enfusion, Inc.

Source Code: ENFN-IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20241101527085/en/

 
    CONTACT:    Investor Relations 

Bill Wright

investors@enfusion.com

Media

media@enfusion.com

 
 

(END) Dow Jones Newswires

November 04, 2024 07:30 ET (12:30 GMT)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10